Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer

Study limitation reported by the research below: “Sex distribution is not explicitly reported in the abstract; 'mixed' is assumed based on typical NSCLC cohort composition.”